A detailed history of Cary Street Partners Financial LLC transactions in Organon & Co. stock. As of the latest transaction made, Cary Street Partners Financial LLC holds 5,493 shares of OGN stock, worth $46,305. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,493
Previous 7,465 26.42%
Holding current value
$46,305
Previous $111 Million 26.57%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 09, 2025

SELL
$14.29 - $16.41 $28,179 - $32,360
-1,972 Reduced 26.42%
5,493 $81.8 Million
Q4 2024

Feb 14, 2025

BUY
$14.44 - $18.83 $107,794 - $140,565
7,465 New
7,465 $111 Million

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $2.14B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Cary Street Partners Financial LLC Portfolio

Follow Cary Street Partners Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Financial LLC with notifications on news.